NASDAQ$AKTS
Aktis Oncology Inc · Q2 2026 earnings
Q2 2026 earnings · · After market close
Reports in 4 weeks
Aktis Oncology Inc hasn't published Q2 2026 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q1 2026
- Revenue
- $3.23M
- EPS
- -$0.38
Revenue & EPS history
Aktis Oncology Inc · Revenue · Quarterly
$3.23M
Q1 2026
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro